Close Menu Phone
Tiffany Lucas

About Tiffany

Tiffany is a Senior Associate in the firm’s corporate, M&A and private clients practice. She provides strategic commercial advice to high-net wealth individuals, entrepreneurs, family groups, private businesses and public companies. She also advises on non-profit and philanthropic matters.

Tiffany has particular expertise in the sale and acquisition of businesses across a range of industries including retail, professional services, pharmaceutical, manufacturing and technology. She also works with private clients in relation to succession planning for themselves, their businesses and their philanthropic endeavours.

Tiffany completed her Juris Doctorate in 2006, (graduating magna cum laude) from The University of Missouri-Kansas City. Additionally, she holds a Bachelor of Science degree (graduating summa cum laude) from Northwest Missouri State University and a Masters of Bioethics from Monash University. Tiffany is admitted to practice in a number of US jurisdictions and in Australia.

Tiffany was appointed as a senior associate at Arnold Bloch Leibler in 2011. From 2013 to 2016 she worked in non-profit management and returned to the firm as a senior associate in 2017.

Practice focus

Tiffany’s practice focuses on the following areas:

  • commercial and corporate advice;
  • mergers and acquisitions;
  • stakeholder agreements, including partnership, shareholder and joint venture agreements;
  • personal and business succession planning, including family agreements; and
  • wealth management, including asset protection, estate planning and philanthropic giving.


Directorships & memberships

Tiffany is a member of the Children’s Bioethics Centre Development Board at the Royal Children’s Hospital in Melbourne.


Tiffany has acted for individuals, family groups and companies in a broad range of transactions, including:

  • the Grenda Family: in relation to the sale of its majority shareholding in the Volgren bus manufacturing business;
  • Slater & Gordon: in relation to the acquisition of numerous legal practices;
  • sass & bide: in relation to the sale of a 65 per cent stake to Myer Holdings Limited;
  • SEEK Limited: in a number of transactions including: acting on its major strategic investment in IDP; its acquisition of the Think Education Group and interests in several overseas employment websites; and its $206 million acquisition of a 60 per cent stake in Jobs DB, an online employment company with operations throughout South–East Asia;
  • Probiotec Limited: in a number of transactions including various acquisitions, sales and supplier relationships;
  • Rathbone Wine Group: in relation to a number of winery and wine brand sales and purchases;
  • Cabrini Health Australia: in relation to its acquisition of Elsternwick Private Hospital;
  • Plenary Group: in relation to the establishment of a joint venture for the development of the Melbourne Convention Centre and the South Wharf Hilton, Melbourne; and
  • Nufarm Limited: in relation to a number of corporate and commercial matters, including several key US and Canadian acquisitions; and the $611 million strategic investment by Sumitomo Chemical Company Limited in April 2010.